Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
Northpond Ventures is a science-driven investment firm that seeks the next breakthroughs by supporting innovators and visionaries to advance science for humanity. Their approach is to build and back breakthrough science- and technology-driven businesses to create a meaningful, measurable impact on humanity. Their portfolio includes companies such as MASS, CAMP, CADL, KYTX, VIGL and TBIO, with several portfolio companies acquired by major organizations including Best Buy, Eli Lilly, Labcorp, Bruker and Vizgen.
Parse Score
#19 of 55 in Biotech and Health Service Providers
Sources
ellty.com shapes more of what AI says about Northpond Ventures than any other source, at 100% of its citations.
The market map
Biotech and Health Service Providers →Where AI ranks Northpond Ventures